The Global Health Supply Chain Program – Procurement and Supply Management (GHSC-PSM) project is an official project of USAID implemented by Chemonics International Inc. and its consortium members. The purpose of GHSC-PSM is to ensure uninterrupted supplies of health commodities in support of U.S. government-funded public health initiatives around the world. The project provides direct procurement and supply chain management support to the President’s Emergency Plan for AIDS Relief (PEPFAR), the President’s Malaria Initiative (PMI), and Population and Reproductive Health (PRH). GHSC-PSM supports health programs through the supply of a wide range of health commodities, including contraceptives and condoms, essential drugs; and select commodities for HIV/AIDS malaria, maternal and child health, and infectious diseases.
Chemonics International Inc., under the GHSC-PSM project (USAID Contract No. AID-OAA-I-15-00004) is soliciting an Expression of Interest (EOI) for supply of Malaria Pharmaceuticals for the countries supported by President’s Malaria Initiative (PMI) funding. GHSC-PSM is soliciting proposals from companies and organizations to participate in the EOI issued by Chemonics. Interested companies or organizations should submit a proposal. Should Chemonics accept a proposal, it will initiate discussions with an aim of establishing a subcontract. Interested companies or organizations should email their response with the complete set of documents (linked below) to email@example.com and firstname.lastname@example.org. Please note that incomplete applications may not be reviewed or may be returned to applicants for revision.
For questions or comments regarding the Expression of Interest, manufacturer or product eligibility, please send your message to email@example.com and firstname.lastname@example.org. Chemonics will provide answers to all relevant questions received.
This is an open EOI. All interested parties must submit their responses by December 31, 2020 at 5 p.m. (EST).
Please review all of the attached annexes, then sign and submit those applicable to the product(s) being offered. The following annexes must be submitted for all products: 2, 3, 5, 6, 7, 9, and 11.
Submissions involving products containing artemisinin must also include annexes 8 and 10.